Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 3:36:101591.
doi: 10.1016/j.rmcr.2022.101591. eCollection 2022.

Autoimmune pulmonary alveolar proteinosis with features similar to nonspecific interstitial pneumonia

Koki Fujii  1 , Hideyuki Takeshima  1 , Taku Nishimura  1 , Toshio Sakatani  1 , Yoshio Masuda  2 , Teppei Morikawa  2 , Kazuhiro Usui  1
Affiliations
Case Reports

Autoimmune pulmonary alveolar proteinosis with features similar to nonspecific interstitial pneumonia

Koki Fujii et al. Respir Med Case Rep. .

Abstract

A 58-year-old woman with cough and dyspnea who was suspected of having idiopathic interstitial pneumonia had been treated with corticosteroids and cyclosporine, but the symptoms had worsened. There were no findings to suspect pulmonary alveolar proteinosis (PAP) in the bronchoalveolar lavage fluid, 17 months after the start of treatment. The transbronchial lung biopsy specimens showed eosinophilic bodies that strongly stained with periodic acid-Schiff staining. Anti-granulocyte macrophage colony-stimulating factor (anti-GM-CSF) antibodies were detected in her serum. We diagnosed the patient with autoimmune PAP. Thus, we present a rare case of PAP presenting atypical radiological images and bronchoalveolar lavage fluid findings.

Keywords: Anti-GM-CSF antibody; Autoimmune pulmonary alveolar proteinosis; Bronchoalveolar lavage fluid; Ground-glass opacities; Nonspecific interstitial pneumonia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Computed tomography images (A) During the first visit, we observed bilateral ground-glass opacities with significant distribution in the peripheral regions. (B) Nine months after the first visit, the abnormal shadows had expanded to neighboring regions. (C) Seventeen months after the first visit, the abnormal shadows had spread in the center.
Fig. 2
Fig. 2
Transbronchial lung biopsy specimens stained with (A) hematoxylin and eosin and (B) periodic acid-Schiff staining. The biopsy specimens contained eosinophilic bodies that stained strongly with periodic acid-Schiff staining.
See this image and copyright information in PMC

References

    1. Wang B.M., Stern E.J., Schmidt R.A., et al. Diagnosing pulmonary alveolar proteinosis: a review and an update. Chest. 1997;111(2):460–466. - PubMed
    1. Trapnell B.C., Whitsett J.A., Nakata K. Pulmonary alveolar proteinosis. N. Engl. J. Med. 2003;349(26):2527–2539. - PubMed
    1. Rosen S.H., Castleman B., Liebow A.A., et al. Pulmonary alveolar proteinosis. N. Engl. J. Med. 1958;258(23):1123–1142. - PubMed
    1. Kitamura T., Tanaka N., Watanabe J., et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1999;190(6):875–880. - PMC - PubMed
    1. Inui N., Chida K., Suda T., et al. A case of pulmonary alveolar proteinosis presenting with peripheral infiltrates. Nihon Kokyuki Gakkai Zasshi. 1999;37(4):333–336. - PubMed

Publication types